Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Standards & Regulation

Manufacture Business Practice

The Importance of Access

Sitting Down With... Chip Davis, President and CEO of the Association for Accessible Medicines (AAM).

Manufacture Small Molecules

Bang the Drum

| Stephanie Sutton

Pharma companies have been raising awareness for years, but patients continue to buy counterfeit medicines online.

Manufacture Formulation

Staying On Trend

| Ali Rajabi-Siabhoomi

From patient-centric design to speciality excipients and security of supply; what are the latest trends in formulation strategies?

Discovery & Development Drug Discovery

Tuning in to Perfect Harmony

| Maryam Mahdi

Industry experts share how their therapeutic products are shaping the future of the pharmaceutical landscape.

Discovery & Development Standards & Regulation

Regulatory Action

| Maryam Mahdi

Is the regulator environment changing fast enough to accommodate the vast array of microbiome-based therapeutics beginning to emerge?

Manufacture Contract Manufacturing Services

When Standardization Meets Customization

| Jeremy Rautenbach

Combine standardized, single-use platform technologies that can be customized to your particular process requirements, for crucial efficiency gains.

Business & Regulation Standards & Regulation

Five Steps You Won't Want to Miss When Filing an IND

| Sponsored by Regis

What are the most important things to consider when filing an IND? This infographic, sponsored by Regis, sets out the five key steps to success.

Business & Regulation Business Practice

GDUFA 2020

| Stephanie Sutton

GDUFA fees for 2020 have been decided – and include a significant drop in the fees for finished dosage facilities.

Business & Regulation Business Practice

Perpetual Preparedness

| James Strachan

With a no-deal Brexit still a real possibility, Merck continues to prepare for the worst case scenario.

Business & Regulation Clinical Trials

Brexit Realities

| James Strachan

Our animation explores the unique challenges a "no-deal" Brexit poses for the drug development and advanced therapy sectors.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register